NCT05464654View on ClinicalTrials.gov

Vaginal Biorevitalization With Polydeoxyribonucleotides for the Improvement of the Genitourinary Syndrome of Menopause

NACompletedINTERVENTIONAL
Enrollment

136

Participants

Timeline

Start Date

June 23, 2021

Primary Completion Date

November 23, 2021

Study Completion Date

December 31, 2022

Conditions
Genitourinary Syndrome of MenopausePostmenopausal DisorderMenopauseVagina Atrophy
Interventions
DRUG

3 g Polynucleotide vaginal suppositories

3 g polynucleotide vaginal suppositories were administered nightly for 6 days.

DRUG

Conjugated estrogens cream 1g Tube

Conjugated estrogen cream 1g was applied intravaginally on Monday, Wednesday and Friday for three months.

Trial Locations (1)

07300

Peri-postmenopause and bone metabolism clinic. Regional Hospital October 1st ISSSTE, Mexico City

All Listed Sponsors
collaborator

Hospital General Regional No. 1 IMSS

OTHER_GOV

collaborator

Universidad Nacional Autonoma de Mexico

OTHER

collaborator

National Polytechnic Institute, Mexico

OTHER

lead

Hospital Regional 1o de Octubre

OTHER